Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

22.84

-0.10 (-0.44%)

At close: May 29, 2026, 4:00 PM EDT

22.94

+0.10 (0.44%)

After-hours: May 29, 2026, 4:10 PM EDT

Kailera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.02	0.02	-
Net Debt / Equity Ratio	1.18	1.50	-
Net Debt / EBITDA Ratio	-	3.39	-
Net Debt / FCF Ratio	-	4.38	-
Quick Ratio	9.47	11.77	-
Current Ratio	9.67	12.01	-
Return on Equity (ROE)	-	-46.85%	-
Return on Assets (ROA)	-	-45.74%	-
Return on Invested Capital (ROIC)	-	-313.94%	-
Return on Capital Employed (ROCE)	-	-49.03%	-
Buyback Yield / Dilution	-	-15600.00%	-
Total Shareholder Return	-	-15600.00%	-

SEC Filings: 10-K · 10-Q